Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.115
-0.035 (-3.04%)
Apr 29, 2026, 10:21 AM EDT - Market open
Canopy Growth Market Cap
Canopy Growth has a market cap or net worth of $439.92 million as of April 29, 2026. Its market cap has increased by 218.09% in one year.
Market Cap
439.92M
Enterprise Value
354.84M
1-Year Change
218.09%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since May 24, 2018, Canopy Growth's market cap has decreased from $5.67B to $439.92M, a decrease of -92.24%. That is a compound annual growth rate of -27.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 434.50M | 11.38% |
| Dec 31, 2025 | 390.10M | 35.12% |
| Dec 31, 2024 | 288.70M | -31.86% |
| Dec 29, 2023 | 423.70M | -62.25% |
| Dec 30, 2022 | 1.12B | -67.34% |
| Dec 31, 2021 | 3.44B | -62.54% |
| Dec 31, 2020 | 9.17B | 26.27% |
| Dec 31, 2019 | 7.26B | 34.51% |
| Dec 31, 2018 | 5.40B | -4.72% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioAge Labs | 756.67M |
| Ironwood Pharmaceuticals | 640.82M |
| Eton Pharmaceuticals | 628.09M |
| Aquestive Therapeutics | 497.94M |
| Esperion Therapeutics | 491.64M |
| Kamada | 471.87M |
| Emergent BioSolutions | 414.71M |
| Akebia Therapeutics | 383.09M |